FdaApplication
ANDA 208075
Identifiers
- fda_app_no: ANDA208075
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2021-09-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFTAROLINE FOSAMIL | CEFTAROLINE FOSAMIL | 400MG/VIAL | POWDER;INTRAVENOUS |
| CEFTAROLINE FOSAMIL | CEFTAROLINE FOSAMIL | 600MG/VIAL | POWDER;INTRAVENOUS |
2 products